Research Summary
Human vaccine adjuvants are substances added to vaccines to enhance the body's immune response to the antigens present in the vaccine. Antigens are the components of vaccines that stimulate the immune system to produce an immune response. Adjuvants serve to amplify and prolong this response, improving the effectiveness of the vaccine. Common adjuvants include aluminum salts, which have been used for decades and are found in many vaccines, as well as newer adjuvants like oil-in-water emulsions. Adjuvants work by triggering a more robust immune response, leading to the activation of immune cells and the production of higher levels of antibodies. This enhanced immune response is particularly important in situations where a stronger and longer-lasting immunity is desired, such as in the development of vaccines for certain infectious diseases. The use of adjuvants allows for the reduction of the amount of antigen needed in a vaccine, which can be advantageous in terms of manufacturing efficiency and safety. Adjuvants play a crucial role in the development of vaccines that provide optimal protection against various pathogens.
According to DIResearch's in-depth investigation and research, the global Human Vaccine Adjuvants market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Human Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Human Vaccine Adjuvants. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Human Vaccine Adjuvants market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Human Vaccine Adjuvants market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Human Vaccine Adjuvants industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Human Vaccine Adjuvants Include:
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
Human Vaccine Adjuvants Product Segment Include:
di_type
Human Vaccine Adjuvants Product Application Include:
Aluminium Salt Adjuvant
Oil Emulsion Adjuvant
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Human Vaccine Adjuvants Industry PESTEL Analysis
Chapter 3: Global Human Vaccine Adjuvants Industry Porter's Five Forces Analysis
Chapter 4: Global Human Vaccine Adjuvants Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Human Vaccine Adjuvants Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Human Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Human Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Human Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Human Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Human Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Human Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Human Vaccine Adjuvants Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Human Vaccine Adjuvants Market Overview 1.1 Product Definition and Statistical Scope 1.2 Human Vaccine Adjuvants Product by Type 1.2.1 Global Human Vaccine Adjuvants Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 di_type 1.3 Human Vaccine Adjuvants Product by Application 1.3.1 Global Human Vaccine Adjuvants Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Aluminium Salt Adjuvant 1.3.3 Oil Emulsion Adjuvant 1.3.4 Others 1.4 Global Human Vaccine Adjuvants Market Revenue and Sales Analysis 1.4.1 Global Human Vaccine Adjuvants Market Size Analysis (2019-2030) 1.4.2 Global Human Vaccine Adjuvants Market Sales Analysis (2019-2030) 1.4.3 Global Human Vaccine Adjuvants Market Sales Price Trend Analysis (2019-2030) 1.5 Human Vaccine Adjuvants Market Development Status and Trends 1.5.1 Human Vaccine Adjuvants Industry Development Status Analysis 1.5.2 Human Vaccine Adjuvants Industry Development Trends Analysis 2 Human Vaccine Adjuvants Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Human Vaccine Adjuvants Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Human Vaccine Adjuvants Market Analysis by Regions 4.1 Human Vaccine Adjuvants Overall Market: 2023 VS 2024 VS 2030 4.2 Global Human Vaccine Adjuvants Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Human Vaccine Adjuvants Revenue and Market Share by Region (2019-2024) 4.2.2 Global Human Vaccine Adjuvants Revenue Forecast by Region (2025-2030) 4.3 Global Human Vaccine Adjuvants Sales and Forecast Analysis (2019-2030) 4.3.1 Global Human Vaccine Adjuvants Sales and Market Share by Region (2019-2024) 4.3.2 Global Human Vaccine Adjuvants Sales Forecast by Region (2025-2030) 4.4 Global Human Vaccine Adjuvants Sales Price Trend Analysis (2019-2030) 5 Global Human Vaccine Adjuvants Market Size by Type and Application 5.1 Global Human Vaccine Adjuvants Market Size by Type 5.1.1 Global Human Vaccine Adjuvants Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Human Vaccine Adjuvants Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Human Vaccine Adjuvants Market Size by Application 5.2.1 Global Human Vaccine Adjuvants Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Human Vaccine Adjuvants Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Human Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Human Vaccine Adjuvants Market Size by Type 6.3.1 North America Human Vaccine Adjuvants Sales by Type (2019-2030) 6.3.2 North America Human Vaccine Adjuvants Revenue by Type (2019-2030) 6.4 North America Human Vaccine Adjuvants Market Size by Application 6.4.1 North America Human Vaccine Adjuvants Sales by Application (2019-2030) 6.4.2 North America Human Vaccine Adjuvants Revenue by Application (2019-2030) 6.5 North America Human Vaccine Adjuvants Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Human Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Human Vaccine Adjuvants Market Size by Type 7.3.1 Europe Human Vaccine Adjuvants Sales by Type (2019-2030) 7.3.2 Europe Human Vaccine Adjuvants Revenue by Type (2019-2030) 7.4 Europe Human Vaccine Adjuvants Market Size by Application 7.4.1 Europe Human Vaccine Adjuvants Sales by Application (2019-2030) 7.4.2 ? Europe Human Vaccine Adjuvants Revenue by Application (2019-2030) 7.5 Europe Human Vaccine Adjuvants Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Human Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Human Vaccine Adjuvants Market Size by Type 8.3.1 China Human Vaccine Adjuvants Sales by Type (2019-2030) 8.3.2 China Human Vaccine Adjuvants Revenue by Type (2019-2030) 8.4 China Human Vaccine Adjuvants Market Size by Application 8.4.1 China Human Vaccine Adjuvants Sales by Application (2019-2030) 8.4.2 China Human Vaccine Adjuvants Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Human Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Human Vaccine Adjuvants Market Size by Type 9.3.1 APAC (excl. China) Human Vaccine Adjuvants Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Human Vaccine Adjuvants Revenue by Type (2019-2030) 9.4 APAC (excl. China) Human Vaccine Adjuvants Market Size by Application 9.4.1 APAC (excl. China) Human Vaccine Adjuvants Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Human Vaccine Adjuvants Revenue by Application (2019-2030) 9.5 APAC (excl. China) Human Vaccine Adjuvants Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Human Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Human Vaccine Adjuvants Market Size by Type 10.3.1 Latin America Human Vaccine Adjuvants Sales by Type (2019-2030) 10.3.2 Latin America Human Vaccine Adjuvants Revenue by Type (2019-2030) 10.4 Latin America Human Vaccine Adjuvants Market Size by Application 10.4.1 Latin America Human Vaccine Adjuvants Sales by Application (2019-2030) 10.4.2 Latin America Human Vaccine Adjuvants Revenue by Application (2019-2030) 10.5 Latin America Human Vaccine Adjuvants Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Human Vaccine Adjuvants Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Human Vaccine Adjuvants Market Size by Type 11.3.1 Middle East & Africa Human Vaccine Adjuvants Sales by Type (2019-2030) 11.3.2 Middle East & Africa Human Vaccine Adjuvants Revenue by Type (2019-2030) 11.4 Middle East & Africa Human Vaccine Adjuvants Market Size by Application 11.4.1 Middle East & Africa Human Vaccine Adjuvants Sales by Application (2019-2030) 11.4.2 Middle East & Africa Human Vaccine Adjuvants Revenue by Application (2019-2030) 11.5 Middle East & Africa Human Vaccine Adjuvants Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Human Vaccine Adjuvants Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Human Vaccine Adjuvants Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Human Vaccine Adjuvants Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Human Vaccine Adjuvants Average Sales Price by Manufacturers (2020-2024) 12.2 Human Vaccine Adjuvants Competitive Landscape Analysis and Market Dynamic 12.2.1 Human Vaccine Adjuvants Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 GSK 13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 GSK Human Vaccine Adjuvants Product Portfolio 13.1.3 GSK Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 CSL Limited 13.2.1 CSL Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 CSL Limited Human Vaccine Adjuvants Product Portfolio 13.2.3 CSL Limited Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Croda 13.3.1 Croda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Croda Human Vaccine Adjuvants Product Portfolio 13.3.3 Croda Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 SEPPIC 13.4.1 SEPPIC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 SEPPIC Human Vaccine Adjuvants Product Portfolio 13.4.3 SEPPIC Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Sanofi 13.5.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Sanofi Human Vaccine Adjuvants Product Portfolio 13.5.3 Sanofi Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Zhifei Biological 13.6.1 Zhifei Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Zhifei Biological Human Vaccine Adjuvants Product Portfolio 13.6.3 Zhifei Biological Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Escon 13.7.1 Escon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Escon Human Vaccine Adjuvants Product Portfolio 13.7.3 Escon Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Huanuotai Biological 13.8.1 Huanuotai Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Huanuotai Biological Human Vaccine Adjuvants Product Portfolio 13.8.3 Huanuotai Biological Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Rico Bio 13.9.1 Rico Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Rico Bio Human Vaccine Adjuvants Product Portfolio 13.9.3 Rico Bio Human Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Human Vaccine Adjuvants Industry Chain Analysis 14.2 Human Vaccine Adjuvants Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Human Vaccine Adjuvants Typical Downstream Customers 14.4 Human Vaccine Adjuvants Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support